Auxilium Biotechnologies reported a historic first: it successfully bioprinted kidney and liver tissues aboard the International Space Station. The milestone supports progress in space-based regenerative medicine, though no financial guidance or market figures were provided.
Auxilium Biotechnologies reported a historic first: it successfully bioprinted kidney and liver tissues aboard the International Space Station. The milestone supports progress in space-based regenerative medicine, though no financial guidance or market figures were provided.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35